ACTU
NASDAQStockActuate Therapeutics Inc
$2.56+0.01 (+0.39%)
52-Week Range
$2.52
$11.90
Key Stats
Market Cap
—
P/E Ratio
—
Dividend Yield
—
Beta
0.12
Volume
72.4K
Avg Volume
81.0K
Performance
1M
-41.11%
3M
-62.83%
6M
-63.78%
YTD
-57.71%
1Y
-65.54%
3Y
-70.38%
5Y
-70.38%
Price Chart
ETF Exposure
ACTU is held by 31 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| IWC | iShares Micro-Cap ETF | 0.01% |
| VTWG | Vanguard Russell 2000 Growth ETF | 0.00% |
| IWM | iShares Russell 2000 ETF | 0.00% |
| IWO | iShares Russell 2000 Growth ETF | 0.00% |
| RSSL | Global X - Russell 2000 ETF | 0.00% |
| UWM | ProShares - Ultra Russell2000 | 0.00% |
| VTWO | Vanguard Russell 2000 ETF | 0.00% |
| VXF | Vanguard Extended Market ETF | 0.00% |
| XRS2.DE | Xtrackers Russell 2000 UCITS ETF 1C | 0.00% |
| XRSU.L | Xtrackers Russell 2000 UCITS ETF 1C | 0.00% |
| XSU.TO | iShares U.S. Small Cap Index ETF (CAD-Hedged) | 0.00% |
| SC0K.DE | Invesco Russell 2000 UCITS ETF | 0.00% |
| HDG | ProShares - Hedge Replication ETF | 0.00% |
| ITDB | iShares LifePath Target Date 2030 ETF | 0.00% |
| ITDC | iShares LifePath Target Date 2035 ETF | 0.00% |
| ITDD | iShares LifePath Target Date 2040 ETF | 0.00% |
| ITDE | iShares LifePath Target Date 2045 ETF | 0.00% |
| ITDF | iShares LifePath Target Date 2050 ETF | 0.00% |
| ITDG | iShares LifePath Target Date 2055 ETF | 0.00% |
| ITDH | iShares LifePath Target Date 2060 ETF | 0.00% |
| ITDI | iShares LifePath Target Date 2065 ETF | 0.00% |
| ITDJ | iShares LifePath Target Date 2070 ETF | 0.00% |
| R2SC.L | State Street SPDR Russell 2000 U.S. Small Cap UCITS ETF (Acc) | 0.00% |
| SMMD | iShares Russell 2500 ETF | 0.00% |
| URTY | ProShares - UltraPro Russell2000 | 0.00% |
| VCNS.TO | Vanguard Conservative ETF Portfolio | 0.00% |
| VEQT.TO | Vanguard All-Equity ETF Portfolio | 0.00% |
| VRIF.TO | Vanguard Retirement Income ETF Portfolio | 0.00% |
| VTI | Vanguard Total Stock Market ETF | 0.00% |
| VUN.TO | Vanguard U.S. Total Market Index ETF | 0.00% |
| VUS.TO | Vanguard U.S. Total Market Index ETF (CAD-hedged) | 0.00% |
About ACTU ETF Exposure
Actuate Therapeutics Inc (ACTU) is held by 31 exchange-traded funds, making it one of the stocks with significant ETF exposure. The stock currently trades at $2.56. Investors can gain exposure to ACTU through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold ACTU, sorted by portfolio weight.